Epiprotect classified as skin substitute will increase reimbursement rates and create market advantages
After extensive investigation, study and evaluation of clinical data found that Epiprotect has wound healing abilities in a larger scale than a typical wound dressing. The company has therefore completed an extensive study to understand why it has been proved to be so successful. The results of the extensive study concluded that Epiprotect in combination with the body’s own proteins creates an active biological material when placed on a wound. The term dressing is therefor no longer the correct medical term and the Company has therefor decided that the term "skin substitute" should be used